Investing.com -- Quantum BioPharma Ltd. (NASDAQ: QNTM) stock fell 5.7% after the company announced it purchased 2,000 shares ...

Biopharmaceutical company Quantum BioPharma said it has acquired 2,000 shares of specialty games and entertainment retailer GameStop in what it calls a strategic investment.

Quantum BioPharma (QNTM) announced the purchase of 2,000 shares of GameStop (GME) to hold on the Company’s balance sheet as a strategic ...

“The Quantum team and I see the extreme value in GameStop going forward and the deep value the company has with 90% cash and marketable securities on their balance sheet,” said Kevin Malone, Board ...

(RTTNews) - Quantum BioPharma Ltd. (QNTM) is having a banner year in 2025, with its share price skyrocketing 730% year-to-date. This biopharmaceutical company is focused on addressing critical ...

Quantum BioPharma shares are surging Thursday after its licensee, Celly Nutrition, engaged a New York investment bank to raise up to $10 million and explore a potential U.S. initial public offering.

Quantum BioPharma drew increased retail buzz on Monday following its announcement of a new $1 million Bitcoin and cryptocurrency investment, which increased its crypto holdings to $4.5 million.

Quantum BioPharma is considered a low-float stock with just 1.83 million shares available for public trading, according to Benzinga Pro. The company also had a market cap of approximately $6 ...

Detailed price information for Quantum Biopharma Ltd (QNTM-Q) from The Globe and Mail including charting and trades.